Randomized Trial of Oral Misoprostol Treatment for Cervical Ripening Before Tandem Application in Cervix Cancer

Çepni, Kimia; Gül, Şule Karabulut; Çepni, İsmail; Güralp, Onur; Sal, Veysel; Mayadağlı, Alpaslan

doi:10.1016/j.ijrobp.2010.06.051

Cited by 5 publications

(2 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For the advantages of hdr brachytherapy to be realized, the method of analgesia must be effective [4][5][6][7] . According to the American Brachytherapy Society, hdr brachytherapy for carcinoma of the cervix should utilize conscious sedation whenever possible 2 .…”

Section: Introductionmentioning

confidence: 99%

Pain Assessment during Conscious Sedation for Cervical Cancer High-Dose-Rate Brachytherapy

et al. 2013

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Pain Assessment during Conscious Sedation for Cervical Cancer High-Dose-Rate Brachytherapy

et al. 2013

View full text Add to dashboard Cite

show abstract

“…in a randomized trial. After 80 patients with evaluated CC, they concluded that the medication taken orally 3 hours before tandem application facilitates the procedure and increases patient’s tolerability and comfort [13].…”

Section: Local Interventionsmentioning

confidence: 99%

Pain relief procedures before high-dose-rate brachytherapy for non-surgical treatment of cervix cancer

Pellizzon

2018

jcb

View full text Add to dashboard Cite

Cervical cancer (CC) is a neoplasm with great potential for prevention, but it is still an important public health problem in most developing countries. No significant difference is found in the literature between intracavitary high-dose-rate (HDR) and low-dose-rate (LDR) brachytherapy, when considering overall, disease specific, and recurrence-free survivals. Cervical dilatation is mandatory for the insertion of intra-uterine tandems for CC intracavitary brachytherapy. Pain and discomfort may eventually be the limiting factors of the procedure, sometimes leading to unsatisfactory results in terms of adequate position of the applicator set. In this paper, we critically reviewed the current sedation and anesthetic options for comfort and safety procedures when performing intracavitary brachytherapy.

show abstract

Overcoming Entrenched Disagreements: the Case of Misoprostol for Post‐Partum Haemorrhage

Ghinea

Lipworth

Little

et al. 2013

Developing World Bioethics

View full text Add to dashboard Cite

The debate about whether misoprostol should be distributed to low resource communities to prevent post-partum haemorrhage (PPH), recognised as a major cause of maternal mortality, is deeply polarised. This is in spite of stakeholders having access to the same evidence about the risks and benefits of misoprostol. To understand the disagreement, we conducted a qualitative analysis of the values underpinning debates surrounding community distribution of misoprostol. We found that different moral priorities, epistemic values, and attitudes towards uncertainty were the main factors sustaining the debate. With this understanding, we present a model for ethical discourse that might overcome the current impasse.

show abstract

Randomized Trial of Oral Misoprostol Treatment for Cervical Ripening Before Tandem Application in Cervix Cancer

Cited by 5 publications

References 18 publications

Pain Assessment during Conscious Sedation for Cervical Cancer High-Dose-Rate Brachytherapy

Pain Assessment during Conscious Sedation for Cervical Cancer High-Dose-Rate Brachytherapy

Pain relief procedures before high-dose-rate brachytherapy for non-surgical treatment of cervix cancer

Overcoming Entrenched Disagreements: the Case of Misoprostol for Post‐Partum Haemorrhage

Contact Info

Product

Resources

About